JPH0558407B2 - - Google Patents
Info
- Publication number
- JPH0558407B2 JPH0558407B2 JP60120328A JP12032885A JPH0558407B2 JP H0558407 B2 JPH0558407 B2 JP H0558407B2 JP 60120328 A JP60120328 A JP 60120328A JP 12032885 A JP12032885 A JP 12032885A JP H0558407 B2 JPH0558407 B2 JP H0558407B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- bath
- oil
- tablets
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000284 extract Substances 0.000 claims description 23
- 239000000654 additive Substances 0.000 claims description 22
- 230000002378 acidificating effect Effects 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 15
- 230000000996 additive effect Effects 0.000 claims description 11
- 229940079593 drug Drugs 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- 239000006096 absorbing agent Substances 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000005187 foaming Methods 0.000 claims description 2
- 241000411851 herbal medicine Species 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000228212 Aspergillus Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- -1 aliphatic dicarboxylic acids Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 239000010446 mirabilite Substances 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 239000001384 succinic acid Substances 0.000 description 2
- ARCGXLSVLAOJQL-UHFFFAOYSA-N trimellitic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 ARCGXLSVLAOJQL-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UHFFFAOYSA-N -2,3-Dihydroxypropanoic acid Natural products OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- VBSTXRUAXCTZBQ-UHFFFAOYSA-N 1-hexyl-4-phenylpiperazine Chemical compound C1CN(CCCCCC)CCN1C1=CC=CC=C1 VBSTXRUAXCTZBQ-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical class CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- FEWFXBUNENSNBQ-UHFFFAOYSA-N 2-hydroxyacrylic acid Chemical compound OC(=C)C(O)=O FEWFXBUNENSNBQ-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical class OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010016334 Feeling hot Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 240000001315 Schisandra repanda Species 0.000 description 1
- 235000014426 Schisandra repanda Nutrition 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JACRWUWPXAESPB-QMMMGPOBSA-N Tropic acid Natural products OC[C@H](C(O)=O)C1=CC=CC=C1 JACRWUWPXAESPB-QMMMGPOBSA-N 0.000 description 1
- 244000126014 Valeriana officinalis Species 0.000 description 1
- 235000013832 Valeriana officinalis Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- VLSMHEGGTFMBBZ-UHFFFAOYSA-N alpha-Kainic acid Natural products CC(=C)C1CNC(C(O)=O)C1CC(O)=O VLSMHEGGTFMBBZ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- RZKNJSIGVZOHKZ-UHFFFAOYSA-N diazanium carbonic acid carbonate Chemical compound [NH4+].[NH4+].OC(O)=O.OC(O)=O.[O-]C([O-])=O RZKNJSIGVZOHKZ-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- TUCSOESCAKHLJM-UHFFFAOYSA-L dipotassium carbonic acid carbonate Chemical compound [K+].[K+].OC(O)=O.OC(O)=O.[O-]C([O-])=O TUCSOESCAKHLJM-UHFFFAOYSA-L 0.000 description 1
- CQAIPTBBCVQRMD-UHFFFAOYSA-L dipotassium;phosphono phosphate Chemical compound [K+].[K+].OP(O)(=O)OP([O-])([O-])=O CQAIPTBBCVQRMD-UHFFFAOYSA-L 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- VLSMHEGGTFMBBZ-OOZYFLPDSA-N kainic acid Chemical compound CC(=C)[C@H]1CN[C@H](C(O)=O)[C@H]1CC(O)=O VLSMHEGGTFMBBZ-OOZYFLPDSA-N 0.000 description 1
- 229950006874 kainic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229910001562 pearlite Inorganic materials 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229940093956 potassium carbonate Drugs 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229910000031 sodium sesquicarbonate Inorganic materials 0.000 description 1
- 235000018341 sodium sesquicarbonate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 1
- 235000016788 valerian Nutrition 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/22—Gas releasing
- A61K2800/222—Effervescent
Description
〔産業上の利用分野〕
本発明は新規な弱酸性入浴剤、更に詳細には、
炭酸塩と酸を含有し、使用時の浴湯PHが弱酸性を
呈する入浴剤に生薬抽出物を安定に配合すること
により、血行促進効果及び肌のしつとり感を相乗
的に高めた弱酸性入浴剤に関する。
〔従来の技術〕
炭酸塩と酸を含有し、浴湯のPHが弱酸性を呈す
る入浴剤は、発生する炭酸ガスが溶液中に留まる
ことにより優れた血行促進作用を示すことが知ら
れている。そして本発明者らは、その浴用効果を
高めるべく、これに生薬を配合した弱酸性入浴剤
を開発した(特願昭59−73507号)。
〔発明が解決しようとする問題点〕
しかしながら、錠剤としてこの生薬を配合した
弱酸性入浴剤を実用化するとき、(1)生薬をそのま
ま配合した場合には、生薬由来の不溶物が浴湯中
にただよい不快感を生ずる、(2)生薬抽出物を用い
た場合は、錠剤中で該抽出物が酸・アルカリの混
合系という過酷な条件下におかれるため、使用時
までに生薬有効成分が分解するなどして効果が低
下したり、異臭が発生する等の欠点があつた。
〔問題点を解決するための手段〕
そこで、本発明者らは斯様な欠点を解消すべく
鋭意研究を行つた結果、生薬抽出物を吸収又は吸
着した吸油剤を顆粒又は錠剤状にし、これを核と
して用いることにより、これらの欠点が悉く解消
されることを見い出し、本発明を完成した。
すなわち、本発明は、生薬抽出物を吸収又は吸
着した吸油剤を顆粒又は錠剤状にし、これを核と
して炭酸塩及び酸を含有する発泡成分中に混入し
て打錠することを特徴とする弱酸性入浴剤を提供
するものである。
本発明の弱酸性入浴剤に配合される炭酸塩とし
ては、例えば炭酸水素ナトリウム、炭酸ナトリウ
ム、セスキ炭酸ナトリウム、炭酸水素カリウム、
炭酸カリウム、セスキ炭酸カリウム、炭酸水素ア
ンモニウム塩、炭酸アンモニウム塩、セスキ炭酸
アンモニウム塩等が挙げられ、これらは単独又は
2種以上を組合わせて使用できる。
また、酸としては、有機酸及び無機酸の何れも
使用できるが、水溶性で固体のものが好ましい。
有機酸としては、例えばギ酸、酢酸、プロピオン
酸、酪酸、吉草酸等の直鎖脂肪酸;シユウ酸、マ
ロン酸、コハク酸、グルタル酸、アジピン酸、ピ
メリン酸、フマル酸、マレイン酸、フタル酸、イ
ソフタル酸、テレフタル酸等のジカルボン酸;グ
ルタミン酸、アスパラギン酸等の酸性アミノ酸;
グリコール酸、乳酸、ヒドロキシアクリル酸、α
−オキシ酪酸、グリセリン酸、タルトロン酸、リ
ンゴ酸、酒石酸、クエン酸、サリチル酸(o、
m、p)、没食子酸、マンデル酸、トロパ酸、ア
スコルビン酸、グルコン酸等のオキシ酸;桂皮
酸、安息香酸、フエニル酢酸、ニコチン酸、カイ
ニン酸、ソルビン酸、ピロリドンカルボン酸、ト
リメリツト酸、ベンゼンスルホン酸、トルエンス
ルホン酸並びにこれら有機酸の酸性塩が挙げられ
る。無機酸としては、例えば、リン酸、リン酸二
水素カリウム、リン酸二水素ナトリウム、亜硫酸
ナトリウム、亜硫酸カリウム、ピロ亜硫酸ナトリ
ウム(メタ重亜硫酸ナトリウム)、ピロ亜硫酸カ
リウム(メタ重亜硫酸カリウム)、酸性ヘキサメ
タリン酸ナトリウム、酸性ヘキサメタリン酸カリ
ウム、酸性ピロリン酸ナトリウム、酸性ピロリン
酸カリウム、スルフアミン酸等が挙げられる。就
中、コハク酸、アジピン酸等の脂肪族ジカルボン
酸、フマル酸、リン酸及びこれらの酸性塩が好ま
しい。
生薬抽出物は特に制限されないが、例えば、ソ
ウジユツ、ビヤクジユツ、カノコソウ、ケイガ
イ、コウボク、センキユウ、トウヒ、トウキ、シ
ヨウキヨウ、シヤクヤク、オウバク、オウゴン、
サンシシ、ケイヒ、ニンジン、ブクリヨウ、トク
ガク、シヨウブ、ガイヨウ、マツブサ、ビヤク
シ、ジユウヤク、ウイキヨウ、チンピ、カンピ、
カミツレ等の生薬からの抽出物が挙げられる。こ
れら生薬は一種又は二種以上の混合物としても使
用することができる。
これらの生薬抽出物としては、上記生薬を水;
エタノール、イソプロパノール等の低級アルコー
ル;大豆油、胡麻油、オリーブ油等の植物油;肝
油、ミンク油、鯨油等の動物油;流動パラフイ
ン、ワセリン等の鉱物;ミリスチン酸イソプロピ
ル、オレイル酸デシルエステル等のエステル油;
多価アルコール化合物等の溶剤又はこれらの2種
以上の混合溶剤で抽出する方法、あるいは炭酸ガ
ス等のガスで抽出する方法等によつて得られる抽
出エキス又は抽出物が挙げられる。就中、水又は
水/アルコールによつて抽出されたものが特に好
ましい。
また、吸油剤としては、上記生薬抽出物の油成
分を吸収、吸着して安定に保持する能力を有する
ものであればよく、例えばデンプン、デキストリ
ン、シクロデキストリン等の天然物;シリカ、ケ
イ酸カルシウム等のケイ酸塩;粘土鉱物、パーラ
イト、カーボンブラツク、ポリウレタン系高分
子、ポリオレフイン系高分子等が挙げられる。こ
れらの吸油剤は、油保持能力が1.5ml/g以上、
特に3ml/g以上のものが好ましい。吸油剤の使
用量は、その種類によつても異なるが、生薬抽出
物の50〜500重量%(以下単に%で示す)が好ま
しい。
本発明の弱酸性入浴剤中の生薬抽出物を充分安
定に保つためには、生薬抽出物を吸収又は吸着し
た吸油剤を顆粒若しくは錠剤状にし(就中、錠剤
状が好ましい)、これを核として炭酸塩及び酸か
らなる発泡成分中に混入して打錠した有核錠剤弱
酸性入浴剤とする必要がある。
この核の形成には、一般に、ソルビツト、マン
ニツト等の糖類;ポリアクリル酸ナトリウム、カ
ルボキシメチルセルロース等の水溶性高分子等の
通常使用されている賦形剤を用いるのが好まし
い。この賦形剤の量は生薬抽出物の20〜500%が
好ましい。
これら顆粒若しくは錠剤状の核は、更に水溶性
高分子状物質で被覆することにより一層の効果が
得られる。
水溶性高分子状物質としては、ヒドロキシエチ
ルセルロース(HEC)、ヒドロキシプロピルセル
ロース(HPC)、ヒドロキシプロピルメチルセル
ロース(HPMC)、ポリエチレングリコール
(PEG)等の水溶性コーテイング剤が好ましい。
本発明弱酸性入浴剤の炭酸塩と酸の配合量は、
入浴剤を浴湯に加えたとき浴湯が弱酸性を呈する
ような比率、すなわち入浴剤の0.01%水溶液がPH
4〜7、特に好ましくはPH6.0〜6.7になるように
することが必要である。PHが4より低いと肌への
刺激が強いと共に風呂釜等をいためる惧れがあ
り、またPHが7を超えると本発明の効果が奏され
ない。
本発明の効果は、PHが酸性の場合には炭酸ガス
はCO2分子として存在して血流促進作用を示す
が、PHがアルカリ性側では炭酸ガスはCO2- 3イオ
ンあるいはHCO- 3イオンとして存在するため当該
効果は全く見られないという原理に基くものであ
る。
斯かる条件を具備するための炭酸塩と酸の配合
量は、これらの種類によつて異なるが、全組成に
対し、炭酸塩は5〜80%特に10〜50%、酸は10〜
80%、特に15〜50%が好ましい。
また、生薬抽出物は、広い範囲の量で配合でき
るが、全組成に対し0.01〜20%、特に0.1〜10%
が好ましい。
更に、本発明入浴剤には、一般に配合されてい
る香料、色素あるいはビタミン類、温泉の有効成
分、酵素、海草エキス、ラノリン、シリコン等を
核部分中、もしくは外殻部分中に配合することが
できる。また製剤化のために必要に応じて賦形
剤、結合剤、崩壊剤、滑沢剤等を添加することも
できる。
〔作用及び発明の効果〕
叙上の如く、本発明の弱酸性入浴剤はPHが人の
肌と大略同一であるので肌に好影響を与える。し
かも浴湯に投ずるとき発生する炭酸ガスは、アル
カリ性ではイオンとして存在するため血流促進効
果はないが、本発明の如く酸性領域ではCO2分子
として存在して肌の血行を促進する優れた効果を
奏する。更にまた、生薬成分の分解による異臭を
発することなく安定に配合された生薬抽出物との
相乗作用で血行促進、保温、肌のしつとり感等す
ぐれた浴用効果を示す。
〔実施例〕
次に実施例を挙げて本発明を詳細に説明する。
実施例 1
センキユウエキス20%とデキストリン75%を混
合し粉末化したものに芒硝3.5%、アビセル1.5%
を混合し、打錠して1錠5gの錠剤(核部分)を
得る。
この錠剤を核部分として、外殻成分が重炭酸ナ
トリウム30%、炭酸ナトリウム15%、コハク酸40
%、芒硝15%、色素微量からなる混合物を打錠
し、1錠50gの錠剤を製造した。これをアルミ製
のフイルムに包装し製品とした。
実施例 2
センキユウエキスをトウキエキスに変えた以外
は実施例1と同様にして1錠50gの入浴剤を製造
した。
実施例 3
センキユウエキスをチンピエキスに変えた以外
は実施例1と同様にして1錠50gの入浴剤を製造
した。
比較例 1
実施例1において、核部分の小錠剤を作らず
に、外殻部分と単純に混合・打錠して1錠50gの
入浴剤を製造した。
比較例 2
実施例2において、核部分の小錠剤を作らず
に、外殻部分と単純に混合・打錠して1錠50gの
入浴剤を製造した。
比較例 3
実施例3において、核部分の小錠剤を作らず
に、外殻部分と単純に混合・打錠して1錠50gの
入浴剤を製造した。
実施例 4
本発明入浴剤の血流量及び皮膚表面温度に対す
る作用を以下の如くして検討した。
<方法>
被験者者8名を対象として、更湯、比較例1の
浴剤添加浴又は本発明による実施例1浴剤添加浴
に10分間入浴させ、入浴前後の各種測定を行つ
た。なお、湯温は40℃、室温25℃であり、入浴剤
は、0.02%溶液となるように希釈して用いた。
測定は、血流計についてはレーザードツプラー
血流計を皮膚表面温度については赤外線温度計を
用いた。
<結果>
測定結果は、表1(血流量)及び表2(皮膚表面
温度)に示した。なお、数値は8名の平均値で示
した。
表1、表2から明らかなように、本発明品が優
れた血行促進効果、保温効果を示すことがわか
る。
[Industrial Application Field] The present invention provides a novel weakly acidic bath additive, more specifically,
By stably blending crude drug extracts into bath additives that contain carbonates and acids, and which have a slightly acidic bath water PH when used, a mild bath additive that synergistically enhances the blood circulation promoting effect and the moisturizing feeling of the skin. Regarding acidic bath additives. [Prior Art] It is known that bath additives that contain carbonate and acid and have a slightly acidic PH of the bath water exhibit excellent blood circulation promoting effects because the carbon dioxide gas generated remains in the solution. . In order to enhance the bathing effect, the present inventors have developed a weakly acidic bath additive containing herbal medicine (Japanese Patent Application No. 73507/1982). [Problems to be solved by the invention] However, when putting into practical use a weakly acidic bath additive containing this crude drug in the form of tablets, (1) If the crude drug is blended as is, insoluble substances derived from the crude drug may be mixed into the bath water. (2) When extracts of herbal medicines are used, the extracts are placed in the harsh conditions of a mixture of acid and alkali in the tablets, so the active ingredients of the herbal medicines are removed by the time of use. However, there were drawbacks such as decomposition, resulting in decreased effectiveness, and the generation of strange odors. [Means for Solving the Problems] Therefore, the present inventors conducted intensive research in order to eliminate such drawbacks, and as a result, they made oil-absorbing agents that absorbed or adsorbed crude drug extracts into granules or tablets. The present invention was completed based on the discovery that all of these drawbacks can be overcome by using the following as a core. That is, the present invention is characterized in that an oil-absorbing agent that has absorbed or adsorbed a herbal medicine extract is made into granules or tablets, and the granules or tablets are mixed into a foaming component containing a carbonate and an acid to form a tablet. It provides acidic bath salts. Examples of carbonates to be added to the weakly acidic bath additives of the present invention include sodium hydrogen carbonate, sodium carbonate, sodium sesquicarbonate, potassium hydrogen carbonate,
Potassium carbonate, potassium sesquicarbonate, ammonium bicarbonate salt, ammonium carbonate salt, ammonium sesquicarbonate salt, etc. are mentioned, and these can be used alone or in combination of two or more kinds. Further, as the acid, both organic acids and inorganic acids can be used, but water-soluble and solid acids are preferred.
Examples of organic acids include straight chain fatty acids such as formic acid, acetic acid, propionic acid, butyric acid, and valeric acid; oxalic acid, malonic acid, succinic acid, glutaric acid, adipic acid, pimelic acid, fumaric acid, maleic acid, phthalic acid, Dicarboxylic acids such as isophthalic acid and terephthalic acid; acidic amino acids such as glutamic acid and aspartic acid;
Glycolic acid, lactic acid, hydroxyacrylic acid, α
-oxybutyric acid, glyceric acid, tartronic acid, malic acid, tartaric acid, citric acid, salicylic acid (o,
m, p), oxyacids such as gallic acid, mandelic acid, tropic acid, ascorbic acid, gluconic acid; cinnamic acid, benzoic acid, phenylacetic acid, nicotinic acid, kainic acid, sorbic acid, pyrrolidonecarboxylic acid, trimellitic acid, benzene Examples include sulfonic acid, toluenesulfonic acid, and acid salts of these organic acids. Examples of inorganic acids include phosphoric acid, potassium dihydrogen phosphate, sodium dihydrogen phosphate, sodium sulfite, potassium sulfite, sodium pyrosulfite (sodium metabisulfite), potassium pyrosulfite (potassium metabisulfite), and acidic hexamethaline. Examples include sodium acid, potassium acid hexametaphosphate, sodium acid pyrophosphate, potassium acid pyrophosphate, and sulfamic acid. Among these, aliphatic dicarboxylic acids such as succinic acid and adipic acid, fumaric acid, phosphoric acid, and acid salts thereof are preferred. Herbal medicine extracts are not particularly limited, but include, for example, Soujiyutsu, Biyakujiyutsu, Valerian, Keigai, Kobokou, Senkiyu, Spruce, Equilibrium, Aspergillus japonica, Syakuyaku, Aspergillus japonica, Aspergillus scutellariae,
Sanshishi, Keihi, Carrot, Bukuriyo, Tokugaku, Shobu, Gaiyo, Matsubusa, Byakushi, Jiyuyaku, Uikiyo, Chimpi, Campi,
Examples include extracts from herbal medicines such as chamomile. These crude drugs can be used alone or as a mixture of two or more. These herbal medicine extracts include the above herbal medicines in water;
Lower alcohols such as ethanol and isopropanol; Vegetable oils such as soybean oil, sesame oil, and olive oil; Animal oils such as cod liver oil, mink oil, and whale oil; Minerals such as liquid paraffin and petrolatum; Ester oils such as isopropyl myristate and decyl oleate;
Examples include extracts obtained by a method of extraction with a solvent such as a polyhydric alcohol compound or a mixed solvent of two or more thereof, or a method of extraction with a gas such as carbon dioxide gas. Among these, those extracted with water or water/alcohol are particularly preferred. In addition, the oil-absorbing agent may be one that has the ability to absorb, adsorb, and stably retain the oil component of the herbal medicine extract, such as natural products such as starch, dextrin, and cyclodextrin; silica, and calcium silicate. silicates such as clay minerals, pearlite, carbon black, polyurethane polymers, polyolefin polymers, etc. These oil absorbers have an oil retention capacity of 1.5ml/g or more,
Particularly preferred is 3 ml/g or more. The amount of the oil-absorbing agent used varies depending on its type, but is preferably 50 to 500% by weight of the herbal medicine extract (hereinafter simply expressed as %). In order to keep the herbal medicine extracts in the weakly acidic bath additives of the present invention sufficiently stable, the oil-absorbing agent that has absorbed or adsorbed the herbal medicine extracts is made into granules or tablets (particularly tablets are preferred), and the oil absorbent is made into granules or tablets. Therefore, it is necessary to prepare a weakly acidic bath salt in the form of a dry-coated tablet, which is mixed into an effervescent component consisting of a carbonate and an acid and then compressed into a tablet. For the formation of this core, it is generally preferable to use commonly used excipients such as saccharides such as sorbitate and mannite; water-soluble polymers such as sodium polyacrylate and carboxymethyl cellulose. The amount of this excipient is preferably 20-500% of the crude drug extract. Further effects can be obtained by coating these granule or tablet cores with a water-soluble polymeric substance. As the water-soluble polymeric substance, water-soluble coating agents such as hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), hydroxypropyl methyl cellulose (HPMC), and polyethylene glycol (PEG) are preferred. The amount of carbonate and acid in the weakly acidic bath additive of the present invention is as follows:
When bath additives are added to bath water, the ratio is such that the bath water becomes slightly acidic, that is, the PH of a 0.01% aqueous solution of bath additives is
It is necessary to adjust the pH to 4 to 7, particularly preferably 6.0 to 6.7. If the pH is lower than 4, there is a risk of strong skin irritation and damage to the bathtub, etc. If the pH is higher than 7, the effects of the present invention will not be achieved. The effect of the present invention is that when the pH is acidic, carbon dioxide gas exists as CO 2 molecules and exhibits a blood flow promoting effect, but when the pH is alkaline, carbon dioxide gas exists as CO 2-3 ions or HCO - 3 ions . This is based on the principle that the effect is not observed at all because the The blending amounts of carbonate and acid to meet these conditions vary depending on their type, but carbonate should be 5 to 80%, particularly 10 to 50%, and acid should be 10 to 50% of the total composition.
80%, especially 15-50% is preferred. In addition, crude drug extracts can be added in a wide range of amounts, but 0.01 to 20%, especially 0.1 to 10% of the total composition.
is preferred. Furthermore, the bath salts of the present invention may contain commonly-used fragrances, pigments, vitamins, hot spring active ingredients, enzymes, seaweed extracts, lanolin, silicone, etc. in the core or outer shell. can. Further, excipients, binders, disintegrants, lubricants, etc. may be added as necessary for formulation. [Operation and Effects of the Invention] As mentioned above, the weakly acidic bath additive of the present invention has a favorable effect on the skin since its pH is approximately the same as that of human skin. Moreover, the carbon dioxide gas generated when pouring into bath water exists as ions in alkaline conditions and has no effect of promoting blood flow, but in acidic conditions as in the present invention, it exists as CO 2 molecules and has an excellent effect of promoting blood circulation in the skin. play. Furthermore, the synergistic effect with the stably blended herbal medicine extract without emitting any off-odor due to the decomposition of the herbal medicine ingredients provides excellent bathing effects such as promotion of blood circulation, heat retention, and a moisturizing feeling on the skin. [Example] Next, the present invention will be explained in detail with reference to Examples. Example 1 Powdered mixture of 20% Senkiyu extract and 75% dextrin, 3.5% Glauber's salt, 1.5% Avicel
Mix and tablet to obtain 5 g tablets (core portion). With this tablet as the core, the outer shell components are 30% sodium bicarbonate, 15% sodium carbonate, and 40% succinic acid.
%, 15% Glauber's Salt, and a trace amount of pigment were compressed into tablets each weighing 50 g. This was packaged in an aluminum film and made into a product. Example 2 A bath salt weighing 50 g per tablet was produced in the same manner as in Example 1, except that the extract was replaced with the Angelica extract. Example 3 A bath salt weighing 50 g per tablet was produced in the same manner as in Example 1, except that the extract was replaced with the extract of the chinpiper. Comparative Example 1 In Example 1, a bath salt of 50 g per tablet was produced by simply mixing and tableting the core part and the outer shell part without making small tablets. Comparative Example 2 In Example 2, a bath additive of 50 g per tablet was produced by simply mixing and tableting the core portion and the outer shell portion without making small tablets. Comparative Example 3 In Example 3, a bath salt of 50 g per tablet was produced by simply mixing and tableting the core part with the outer shell part without making small tablets. Example 4 The effect of the bath additive of the present invention on blood flow and skin surface temperature was investigated as follows. <Method> Eight subjects were allowed to take a bath for 10 minutes in a hot bath, a bath with added bath additives in Comparative Example 1, or a bath with added bath agents in Example 1 according to the present invention, and various measurements were taken before and after taking the bath. The water temperature was 40°C and the room temperature was 25°C, and the bath additives were diluted to a 0.02% solution. For measurement, a laser Doppler blood flow meter was used for the blood flow meter, and an infrared thermometer was used for the skin surface temperature. <Results> The measurement results are shown in Table 1 (blood flow) and Table 2 (skin surface temperature). In addition, the numerical value was shown as the average value of 8 people. As is clear from Tables 1 and 2, it can be seen that the products of the present invention exhibit excellent blood circulation promoting effects and heat retention effects.
【表】
たときの相対値を示した。
[Table] Shows relative values when
【表】
実施例 5
実施例1〜3、比較例1〜3の入浴剤を調製
し、各入浴剤を0.03%溶液になるように浴湯に投
入し、パネラー10名に1ケ月間常法に従つて使用
してもらい、入浴剤としての全体評価(総合的な
使用感)、あたたまり感、湯冷めの有無及び肌の
しつとり感を調べた。その結果を表3に示す。い
ずれも実施例がすぐれていることがわかる。[Table] Example 5 The bath additives of Examples 1 to 3 and Comparative Examples 1 to 3 were prepared, each bath additive was added to bath water to make a 0.03% solution, and 10 panelists were given a standard method for one month. The bath additives were used according to the instructions, and the overall evaluation (overall feeling of use) as a bath additive, the feeling of warmth, whether or not the water cooled, and the feeling of moisturizing the skin were evaluated. The results are shown in Table 3. It can be seen that the examples are excellent in all cases.
Claims (1)
又は錠剤状にし、これを核として炭酸塩及び酸を
含有する発泡成分中に混入して打錠することを特
徴とする弱酸性入浴剤。1. A weakly acidic bath additive characterized by granulating or tableting an oil-absorbing agent that has absorbed or adsorbed crude drug extracts, and mixing the granules or tablets as a core into a foaming component containing carbonate and acid to form a tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60120328A JPS61277611A (en) | 1985-06-03 | 1985-06-03 | Weakly acidic bathing agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP60120328A JPS61277611A (en) | 1985-06-03 | 1985-06-03 | Weakly acidic bathing agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61277611A JPS61277611A (en) | 1986-12-08 |
JPH0558407B2 true JPH0558407B2 (en) | 1993-08-26 |
Family
ID=14783536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60120328A Granted JPS61277611A (en) | 1985-06-03 | 1985-06-03 | Weakly acidic bathing agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61277611A (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01172319A (en) * | 1987-12-25 | 1989-07-07 | Nissan Setsuken Kk | Effervescent bathing agent composition |
JP2544297B2 (en) * | 1993-08-27 | 1996-10-16 | 花王株式会社 | Effervescent tablet type bath agent containing capsules |
CN100412182C (en) * | 2003-12-03 | 2008-08-20 | 吴广权 | Bathing bead and method for preparing the same |
JP2014210734A (en) * | 2013-04-19 | 2014-11-13 | クラシエホームプロダクツ株式会社 | Acidic bath composition |
US20180369095A1 (en) | 2015-12-21 | 2018-12-27 | L'oreal | Cosmetic composition comprising a specific filler combination and a film-forming polymer to increase long-lasting effects |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5432616A (en) * | 1977-08-17 | 1979-03-10 | Tsumura Juntendo Kk | Bathing agent |
JPS5970609A (en) * | 1982-10-14 | 1984-04-21 | Kao Corp | Weakly acidic bathing agent |
-
1985
- 1985-06-03 JP JP60120328A patent/JPS61277611A/en active Granted
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5432616A (en) * | 1977-08-17 | 1979-03-10 | Tsumura Juntendo Kk | Bathing agent |
JPS5970609A (en) * | 1982-10-14 | 1984-04-21 | Kao Corp | Weakly acidic bathing agent |
Also Published As
Publication number | Publication date |
---|---|
JPS61277611A (en) | 1986-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR940007919B1 (en) | Weakly acidic bath salt composition | |
US5955057A (en) | Effervescing or foaming bath shape or solid | |
DE69224024T2 (en) | TORF-DERIVATED BIOACTIVE PRODUCTS AND THEIR CONTAINING PHARMACEUTICAL AND COSMETIC COMPOSITIONS | |
JP2000229841A (en) | Mixed type bath preparation | |
JPH0558407B2 (en) | ||
JP2622574B2 (en) | Bath additive | |
JP2523311B2 (en) | Bath agent | |
JP2544102B2 (en) | Weakly acidic bath salt | |
JPS61225117A (en) | Weakly acidic bathing agent | |
JPS60215617A (en) | Weak-acidity bath preparation | |
JP3535985B2 (en) | Cosmetic pack and method for producing the same | |
JPH0334919A (en) | Bathing agent | |
JPS60215618A (en) | Weak-acidity bath preparation | |
JP2765675B2 (en) | Granular cosmetic | |
JP2973368B2 (en) | Bath composition | |
JPS60215613A (en) | Weak-acidity bath preparation | |
JP4197084B2 (en) | Bath cosmetics | |
JPH0717850A (en) | Bathing composition | |
JP3340943B2 (en) | Bath composition | |
JPS632927B2 (en) | ||
JPH1160468A (en) | Composition for bathing | |
JP2001226253A (en) | Bathing agent | |
JP2613862B2 (en) | Bath composition | |
JP2004010543A (en) | Granule used as turbidity-forming agent, method for producing the same, and bath agent composition containing the granule | |
JPH08766B2 (en) | Weakly acidic bath salt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |